Dr. Monty Pal discusses how patient- and disease-specific characteristics influence treatment sequencing decisions for advanced renal cell carcinoma (RCC) beyond the first-line setting.

Dr. Monty Pal discusses the growing importance of quality of life and long-term tolerability when selecting subsequent ...

The single-arm trial met its primary end point of complete response (CR) at any time, exceeding historic and contemporary ...

Targeted Oncology™ is a leading omnichannel resource for community oncologists, offering innovative learning and peer interaction through print and digital platforms. Our custom programs meet your ...